ArticleFrontiers in cardiovascular medicine2021

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis.

Brett W Sperry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.